NextPlat (NXPL) Interest Coverage Ratio Growth (3y) (2019 - 2025)
Powered by 
Analysis
NextPlat (NXPL) Interest Coverage Ratio Growth (3y) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -72.71% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 40.53% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 13.10% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 19.93% |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | -16.49% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 370.83% |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 12.06% |
| Sep 30, 2025 | 16.96% |
| Jun 30, 2025 | 33.60% |
| Mar 31, 2025 | 23.38% |
| Dec 31, 2024 | 51.68% |
| Sep 30, 2024 | 27.08% |
| Jun 30, 2024 | -894.05% |
| Mar 31, 2024 | -434.60% |
| Dec 31, 2023 | -663.02% |
| Sep 30, 2023 | -367.56% |
| Jun 30, 2023 | -513.40% |
| Mar 31, 2023 | -390.69% |
| Dec 31, 2022 | -395.96% |
| Sep 30, 2022 | -438.26% |
| Dec 31, 2021 | -599.21% |
| Jun 30, 2020 | -101.11% |
| Dec 31, 2019 | -115.50% |
| Sep 30, 2019 | 86.84% |